India’s 1st SaaS Based Financial
Products Distributors Network
Products Distributors Network
| Name | Sector | Instrument Type | Assets(%) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | -- | 24.69 |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | -- | 24.69 |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | -- | 24.69 |
| Dr. Reddy'S Laboratories Ltd | Pharmaceuticals | -- | 10.93 |
| Dr. Reddy'S Laboratories Ltd | Pharmaceuticals | -- | 10.93 |
| Dr. Reddy'S Laboratories Ltd | Pharmaceuticals | -- | 10.93 |
| Cipla Ltd | Pharmaceuticals | -- | 10.78 |
| Cipla Ltd | Pharmaceuticals | -- | 10.78 |
| Cipla Ltd | Pharmaceuticals | -- | 10.78 |
| Divi'S Laboratories Ltd | Pharmaceuticals | -- | 8.34 |
| Divi'S Laboratories Ltd | Pharmaceuticals | -- | 8.34 |
| Divi'S Laboratories Ltd | Pharmaceuticals | -- | 8.34 |
| Lupin Ltd | Pharmaceuticals | -- | 6.14 |
| Lupin Ltd | Pharmaceuticals | -- | 6.14 |
| Lupin Ltd | Pharmaceuticals | -- | 6.14 |
| Aurobindo Pharma Ltd | Pharmaceuticals | -- | 5.36 |
| Aurobindo Pharma Ltd | Pharmaceuticals | -- | 5.36 |
| Aurobindo Pharma Ltd | Pharmaceuticals | -- | 5.36 |
| Zydus Lifesciences Ltd | Pharmaceuticals | -- | 4.17 |
| Zydus Lifesciences Ltd | Pharmaceuticals | -- | 4.17 |
| Zydus Lifesciences Ltd | Pharmaceuticals | -- | 4.17 |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals | -- | 3.85 |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals | -- | 3.85 |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals | -- | 3.85 |
| Alkem Laboratories Ltd | Pharmaceuticals | -- | 3.54 |
| Alkem Laboratories Ltd | Pharmaceuticals | -- | 3.54 |
| Alkem Laboratories Ltd | Pharmaceuticals | -- | 3.54 |
| Glenmark Pharmaceuticals Ltd | Pharmaceuticals | -- | 2.92 |
| Glenmark Pharmaceuticals Ltd | Pharmaceuticals | -- | 2.92 |
| Glenmark Pharmaceuticals Ltd | Pharmaceuticals | -- | 2.92 |
| Mankind Pharma Ltd | Pharmaceuticals | -- | 2.49 |
| Mankind Pharma Ltd | Pharmaceuticals | -- | 2.49 |
| Mankind Pharma Ltd | Pharmaceuticals | -- | 2.49 |
| Laurus Labs Ltd | Pharmaceuticals | -- | 2.43 |
| Laurus Labs Ltd | Pharmaceuticals | -- | 2.43 |
| Laurus Labs Ltd | Pharmaceuticals | -- | 2.43 |
| Ipca Laboratories Ltd | Pharmaceuticals | -- | 2.34 |
| Ipca Laboratories Ltd | Pharmaceuticals | -- | 2.34 |
| Ipca Laboratories Ltd | Pharmaceuticals | -- | 2.34 |
| Biocon Ltd | Pharmaceuticals | -- | 2.14 |
| Biocon Ltd | Pharmaceuticals | -- | 2.14 |
| Biocon Ltd | Pharmaceuticals | -- | 2.14 |
| Abbott India Ltd | Pharmaceuticals | -- | 2 |
| Abbott India Ltd | Pharmaceuticals | -- | 2 |
| Abbott India Ltd | Pharmaceuticals | -- | 2 |
| Gland Pharma Ltd | Pharmaceuticals | -- | 1.97 |
| Gland Pharma Ltd | Pharmaceuticals | -- | 1.97 |
| Gland Pharma Ltd | Pharmaceuticals | -- | 1.97 |
| JB Chemicals & Pharmaceuticals Ltd | Pharmaceuticals | -- | 1.83 |
| JB Chemicals & Pharmaceuticals Ltd | Pharmaceuticals | -- | 1.83 |
| JB Chemicals & Pharmaceuticals Ltd | Pharmaceuticals | -- | 1.83 |
| TREPS | Cash/Deposits/Margins/Treps/Repo/Swaps | -- | 1.74 |
| TREPS | Cash/Deposits/Margins/Treps/Repo/Swaps | -- | 1.74 |
| TREPS | Cash/Deposits/Margins/Treps/Repo/Swaps | -- | 1.74 |
| Natco Pharma Ltd | Pharmaceuticals | -- | 1.64 |
| Natco Pharma Ltd | Pharmaceuticals | -- | 1.64 |
| Natco Pharma Ltd | Pharmaceuticals | -- | 1.64 |
| Granules India Ltd | Pharmaceuticals | -- | 1.14 |
| Granules India Ltd | Pharmaceuticals | -- | 1.14 |
| Granules India Ltd | Pharmaceuticals | -- | 1.14 |
| Sanofi India Ltd | Pharmaceuticals | -- | 0.79 |
| Sanofi India Ltd | Pharmaceuticals | -- | 0.79 |
| Sanofi India Ltd | Pharmaceuticals | -- | 0.79 |
| Sanofi Consumer Healthcare India Ltd | Pharmaceuticals & Biotechnology | -- | 0.38 |
| Sanofi Consumer Healthcare India Ltd | Pharmaceuticals & Biotechnology | -- | 0.38 |
| Sanofi Consumer Healthcare India Ltd | Pharmaceuticals & Biotechnology | -- | 0.38 |
| Cash/Bank/Net Current Assets/(Liabilities) | Cash/Deposits/Margins/Treps/Repo/Swaps | -- | -1.62 |
| Cash/Bank/Net Current Assets/(Liabilities) | Cash/Deposits/Margins/Treps/Repo/Swaps | -- | -1.62 |
| Cash/Bank/Net Current Assets/(Liabilities) | Cash/Deposits/Margins/Treps/Repo/Swaps | -- | -1.62 |
| Asset Class | Percentage |
|---|---|
| Equity | 99.8804 |
| Debt | 0 |
| Cash |
| Sector | Holding Percentage |
|---|---|
| Pharmaceuticals | 298.47 |
| Pharmaceuticals & Biotechnology | 1.14 |
| Cash/Deposits/Margins/Treps/Repo/Swaps | 0.36 |
| Standard Dev. | |
|---|---|
| P/E Ratio | 41.0429 |
| Sharpe |
| Alpha | |
|---|---|
| Beta | |
| Sortino |
| Minimum for 1st Investment | 1000 |
|---|---|
| Minimum for SIP | 1000 |
| 1Y | 3Y | 5Y | |
|---|---|---|---|
| Fund returns | 50.14 | ||
| Category average | -2.1 | 8.2 | 5.3 |
| Rank with in category |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
| Rank (total assets) | --- |
|---|---|
| Total AUM | ₹8,66,712.98Cr |
| Date of Incorporation | --- |
|---|
| Fund benchmark | NIFTY Pharma |
|---|